drug_type
RELEVANT_DRUG
intervention_type
Biologic - T-cell–engaging trispecific antibody
drug_description
Subcutaneous T-cell–engaging trispecific antibody that binds BCMA and GPRC5D on myeloma cells and CD3 on T cells, redirecting T-cell cytotoxicity.
nci_thesaurus_definition
NCI thesaurus definition not available.
drug_category
TRISPECIFIC T ENGAGER
drug_class
Engager
drug_delivery_route
Subcutaneous
drug_mechanism_of_action
Subcutaneous trispecific antibody that binds BCMA and GPRC5D on myeloma cells and CD3 on T cells, bridging them to activate CD3 signaling and redirect T-cell cytotoxicity for targeted lysis of malignant plasma cells.
drug_name
JNJ-79635322 (ramantamig)
nct_id_drug_ref
NCT06768489